Prediction of the Pathogens That Are the Cause of Pneumonia by the Battlefield Hypothesis

Commensal organisms are frequent causes of pneumonia. However, the detection of these organisms in the airway does not mean that they are the causative pathogens; they may exist merely as colonizers. In up to 50% cases of pneumonia, the causative pathogens remain unidentified, thereby hampering targeting therapies. In speculating on the role of a commensal organism in pneumonia, we devised the battlefield hypothesis. In the “pneumonia battlefield,” the organism-to-human cell number ratio may be an index for the pathogenic role of the organism. Using real-time PCR reactions for sputum samples, we tested whether the hypothesis predicts the results of bacteriological clinical tests for 4 representative commensal organisms: Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas spp., and Moraxella catarrhalis. The cutoff value for the organism-to-human cell number ratio, above which the pathogenic role of the organism was suspected, was set up for each organism using 224 sputum samples. The validity of the cutoff value was then tested in a prospective study that included 153 samples; the samples were classified into 3 groups, and each group contained 93%, 7%, and 0% of the samples from pneumonia, in which the pathogenic role of Streptococcus pneumoniae was suggested by the clinical tests. The results for Haemophilus influenzae, Pseudomonas spp., and Moraxella catarrhalis were 100%, 0%, and 0%, respectively. The battlefield hypothesis enabled legitimate interpretation of the PCR results and predicted pneumonia in which the pathogenic role of the organism was suggested by the clinical test. The PCR reactions based on the battlefield hypothesis may help to promote targeted therapies for pneumonia. The prospective observatory study described in the current report had been registered to the University Hospital Medical Information Network (UMIN) registry before its initiation, where the UMIN is a registry approved by the International Committee of Medical Journal Editors (ICMJE). The UMIN registry number was UMIN000001118: A prospective study for the investigation of the validity of cutoff values established for the HIRA-TAN system (April 9, 2008).

[1]  P. Vandamme,et al.  PCR-Based Assay for Differentiation of Pseudomonas aeruginosa from Other Pseudomonas Species Recovered from Cystic Fibrosis Patients , 2004, Journal of Clinical Microbiology.

[2]  Jonathan Cohen,et al.  The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit , 2005, Critical care medicine.

[3]  Miller Dl A STUDY OF TECHNIQUES FOR THE EXAMINATION OF SPUTUM IN A FIELD SURVEY OF CHRONIC BRONCHITIS. , 1963 .

[4]  K. Kitada,et al.  [Detection of Pneumocystis carinii with DNA amplification]. , 1992, Nihon rinsho. Japanese journal of clinical medicine.

[5]  N. Miyashita,et al.  The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. , 2006, Internal medicine.

[6]  Spilf What should the initial antibiotherapy for acute community acquired pneumonia be? How should it be reassessed in case of failure, given the evolution of responsible pathogens and the resistance of pneumococci? Should combined treatment be used? , 2001 .

[7]  A. Videla,et al.  Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. , 2000, Chest.

[8]  Matthew Bidwell Goetz,et al.  Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. , 2005, Chest.

[9]  Naoko Chiba,et al.  Simultaneous Detection of Pathogens in Clinical Samples from Patients with Community-Acquired Pneumonia by Real-Time PCR with Pathogen-Specific Molecular Beacon Probes , 2006, Journal of Clinical Microbiology.

[10]  古谷 良輔,et al.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[11]  E. Claas,et al.  Rapid and Sensitive Method Using Multiplex Real-Time PCR for Diagnosis of Infections by Influenza A and Influenza B Viruses, Respiratory Syncytial Virus, and Parainfluenza Viruses 1, 2, 3, and 4 , 2004, Journal of Clinical Microbiology.

[12]  J. Scott,et al.  Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya , 2000, The Lancet.

[13]  J Hacker,et al.  Evolution of microbial pathogens. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[14]  P. Devos,et al.  Hospital-acquired pneumonia: risk factors for antimicrobial-resistant causative pathogens in critically ill patients. , 2003, Chest.

[15]  A. Jatakanon,et al.  Community-acquired pneumonia in southeast Asia: the microbial differences between ambulatory and hospitalized patients. , 2003, Chest.

[16]  Diagnosis of nosocomial pneumonia in medical ward: repeatability of the protected specimen brush. , 2001, The European respiratory journal.

[17]  T. Nukiwa,et al.  Evaluation of dosing designs of carbapenems for severe respiratory infection using Monte Carlo simulation , 2007, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[18]  Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines , 2003, European Respiratory Journal.

[19]  A. Gascoigne,et al.  Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy , 2008, The Journal of antimicrobial chemotherapy.

[20]  G. Rubenfeld,et al.  The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness. , 2001, The Journal of infectious diseases.

[21]  A. Torres,et al.  Guidelines for the management of adult lower respiratory tract infections , 2005, European Respiratory Journal.

[22]  K. Yanagihara,et al.  Multicenter survey on hospital-acquired pneumonia and the clinical efficacy of first-line antibiotics in Japan. , 2008, Internal medicine.

[23]  N. Miyashita,et al.  Etiology of community-acquired pneumonia requiring hospitalization in Japan. , 2001, Chest.

[24]  Sheldon P Stone,et al.  Community-acquired pneumonia , 1998, The Lancet.

[25]  T. Nakayama,et al.  Novel Technique of Quantitative Nested Real-Time PCR Assay for Mycobacterium tuberculosis DNA , 2006, Journal of Clinical Microbiology.

[26]  L. Mandell,et al.  Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  A. Ruiz-González,et al.  Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. , 1999, The American journal of medicine.

[28]  T. File Community-acquired pneumonia , 2003, The Lancet.

[29]  M. Leinonen,et al.  role of serum troponin levels combined with electrocardiographic findings Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines , 2001 .